Major Indexes Rise After Tumbling Monday; AMD Stock Surges on Meta Chips Deal

Novo Nordisk Cuts US List Prices for GLP-1 Drugs; Stock Continues to Fall

FROM 1 hr 45 min ago

Novo Nordisk (NVO) is slashing U.S. list prices for its GLP-1 medications. The move is not reversing its stock slide.

U.S.-listed shares of Novo Nordisk fell about 3.5% in premarket trading Tuesday, a day after they sank 16% to their lowest level in nearly five years after the Danish firm’s CagriSema obesity treatment delivered less weight loss than that of Eli Lilly’s (LLY) Zepbound.

Before the bell, Novo Nordisk said that effective Jan. 1, 2027, it would lower the list price of Wegovy 2.4-mg injection and 25-mg tablets, Ozempic 0.5-mg, 1-mg, and 2-mg injections, and Rybelsus 7-mg or 14-mg tablets to $675. That would represent reductions from the current list price of approximately 50% and 35% for Wegovy and Ozempic, respectively.

The move “addresses access barriers to our innovative medicines, especially for patients whose out-of-pocket costs are linked to list price,” Novo Nordisk said, adding that the “changes in list price do not have an impact on direct-to-patient, self-pay prices.”

U.S.-listed shares of Novo Nordisk entered the day having lost 56% of their value over the past 12 months. Lilly shares slipped about 1.5% before the bell but have gained 20% over the past year.

Here’s How Much Salesforce Stock Is Expected to Move After Earnings Wednesday

FROM 2 hr 31 min ago

Salesforce is slated to report earnings after the market closes on Wednesday, with traders anticipating a big move from the software giant’s stock in the days that follow.

Based on current options pricing, traders expect Salesforce (CRM) stock could swing up to 9% in either direction by the end of the week. A move of that magnitude from Monday’s close could bring the stock back above $194, recovering some of its recent losses, or drag it down to $162, its lowest level in three years.

Salesforce’s stock has lost about a third of its value since the start of the year amid a broader rout in software stocks after new AI tools from Anthropic added fuel to worries about the technology’s potential to disrupt the industry. 

Analysts at UBS and Oppenheimer recently cut their price targets for Salesforce to $200 and $275, respectively, ahead of Wednesday’s results. They suggested Salesforce’s growth could be muted in the short term as the company faces some headwinds from growing competition and field checks suggested customers may be watching their spending.

Salesforce is seen reporting adjusted earnings per share of $3.05 on a 12% year-over-year jump in revenue to a record $11.18 billion for the fourth quarter, according to estimates compiled by Visible Alpha.

Analysts have largely stayed bullish on Salesforce despite the software giant’s recent slump. Of the 20 analysts with current ratings tracked by Visible Alpha, 15 have “buy” or equivalent ratings compared to five “hold” ratings. Their average price target of $313 would imply upside of more than 75% from Monday’s close.

–Aaron McDade

AMD Stock Soars on Massive AI Chips Deal With Meta

FROM 2 hr 58 min ago

As part of a massive deal for AI computing power, Meta Platforms may wind up owning up to roughly 10% of Advanced Micro Devices’ stock. AMD investors evidently are enthusiastic about the news.

AMD (AMD) shares soared 10% in premarket trading Tuesday after the semiconductor giant inked a deal with Meta (META) to provide the Facebook and Instagram parent with 6 gigawatts of AMD Instinct GPUs to power its AI infrastructure.

Financial terms weren’t disclosed but The Wall Street Journal reported the deal was worth more than $100 billion.

The companies said that shipments supporting the first gigawatt deployment are set to begin in the second half of 2026.

As part of the transaction, Santa Clara, Calif.-based AMD issued Meta a performance-based warrant for up to 160 million shares of its stock, “structured to vest as specific milestones associated with Instinct GPU shipments are achieved.” AMD currently has just over 1.6 billion outstanding shares.

“We’re excited to form a long-term partnership with AMD to deploy efficient inference compute and deliver personal superintelligence,” Meta founder and CEO Mark Zuckerberg said. “This is an important step for Meta as we diversify our compute. I expect AMD to be an important partner for many years to come.”

AMD shares entered the day down about 8% year-to-date, having dropped sharply earlier this month despite reporting strong quarterly results. Meta shares, which are down roughly 3.5% in 2026, edged lower before the bell, while AMD rival Nvidia (NVDA), which reports its highly anticipated earnings Wednesday, slipped more than 1%.

Stock Futures Edge Higher After Indexes Tumble on Tariff Uncertainty, AI Disruption Concerns

FROM 4 hr 5 min ago

Futures contracts connected to the Dow Jones Industrial Average pointed 0.3% higher.

S&P 500 futures were up 0.2%.

Nasdaq 100 futures also were up 0.2%.